TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15761751

Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme (ACE) inhibitors
Number of subjects: 735
Study: 12718708

Group type: EXPERIMENTAL
Intervention: Diaphragmatic Breathing (DB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pursed-Lip Breathing (PLB)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of DB and PLB (CB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Spontaneous Breathing (SB)
Number of subjects: 30
Study: 10325912

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (budesonide 600 micrograms daily)
Number of subjects: 102
Study: 9061129

Group type: EXPERIMENTAL
Intervention: Gericomplex (ginseng, vitamins, minerals and trace elements) - 2 capsules daily for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo capsules - identical in appearance to Gericomplex
Number of subjects: 60
Study: 1899204

Group type: EXPERIMENTAL
Intervention: Carbon dioxide adjustment (PETCO2 between 20 and 80 mmHg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler sonography
Number of subjects: 13
Study: 6576293

Group type: EXPERIMENTAL
Intervention: Formocresol technique
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 76
Study: 31343585

Group type: EXPERIMENTAL
Intervention: WCD-guided 6MWT at home
Number of subjects: 197

Group type: COMPARATOR
Intervention: In-clinic clinician-guided 6MWT
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Weekly unsupervised WCD-guided 6MWTs at home
Number of subjects: 197
Study: 30499790

Group type: EXPERIMENTAL
Intervention: Nurse-delivered education and skill-building intervention
Number of subjects: 10
Study: 28497756

Group type: EXPERIMENTAL
Intervention: S-1 (80 mg/m2, 80-120 mg per day, twice daily for 28 days)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: S-1
Number of subjects: 334
Study: 26578538

Group type: EXPERIMENTAL
Intervention: Condom use
Number of subjects: 911

Group type: COMPARATOR
Intervention: Unprotected sex acts
Number of subjects: 911
Study: 24439462

Group type: EXPERIMENTAL
Intervention: Intravitreal therapy using ranibizumab (n = 11)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravitreal therapy using bevacizumab (n = 20)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravitreal therapy using triamcinolone (n = 19)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravitreal therapy (all types combined)
Number of subjects: 50
Study: 21766975

Group type: EXPERIMENTAL
Intervention: Computer-delivered interventions (CDI)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Booster session
Number of subjects: 225

Group type: COMPARATOR
Intervention: Brief Motivational Interventions (BMI)
Number of subjects: 225
Study: 19178624

Group type: EXPERIMENTAL
Intervention: Technique 1 (T1): direct technique with square copings without union in open trays
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Technique 2 (T2): square copings splinted with dental floss and autopolymerizing acrylic resin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Technique 3 (T3): square copings splinted with dental floss and autopolymerizing acrylic resin, sectioned and splinted again with autopolymerizing acrylic resin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Technique 4 (T4): square copings splinted with prefabricated acrylic resin bar
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group: metal matrix containing two implants
Number of subjects: 24
Study: 17209145

Group type: EXPERIMENTAL
Intervention: PRIME‐MD Patient Questionnaire Depression module
Number of subjects: 1632

Group type: EXPERIMENTAL
Intervention: PRIME‐MD Patient Questionnaire Anxiety module
Number of subjects: 1632

Group type: EXPERIMENTAL
Intervention: Combined PRIME‐MD Patient Questionnaire screen
Number of subjects: 1632

Group type: EXPERIMENTAL
Intervention: Overall accuracy of PRIME‐MD Patient Questionnaire
Number of subjects: 1632
Study: 15547123

Group type: EXPERIMENTAL
Intervention: 5 degrees varus rearfoot wedging
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 5 degrees valgus rearfoot wedging
Number of subjects: 30

Group type: COMPARATOR
Intervention: rearfoot varus wedging
Number of subjects: 30
Study: 11442739

Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD) 20 mg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus scaling and root planing (SRP)
Number of subjects: 0
Study: 9439561

Group type: EXPERIMENTAL
Intervention: Sulfonylurea therapy (gliclazide, ≤ 160 mg.d‐1)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group (double-blind placebo or no tablets)
Number of subjects: 227
Study: 7946771

Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 2438647

Group type: EXPERIMENTAL
Intervention: PCOP combination for 6 months followed by chlorambucil or CVP for 12 months
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: PACOP for 6 months followed by chlorambucil or CVP for 12 months
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Alpha recombinant interferon
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Combined use of interferon and chemotherapy (proposed for future trials)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 113
Study: 27188405

Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 36
Study: 24456239

Group type: EXPERIMENTAL
Intervention: Modified tubeless PCNL with tethered DJ stent
Number of subjects: 166

Group type: COMPARATOR
Intervention: Standard PCNL with nephrostomy tube
Number of subjects: 166
Study: 22424400

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour group therapy (15-week manualized group therapy)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Waiting list (4 months without treatment)
Number of subjects: 36
Study: 20683580

Group type: EXPERIMENTAL
Intervention: Indwelling urinary catheter (IUC) for 24 h
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Indwelling urinary catheter (IUC) for 96 h
Number of subjects: 257

Group type: COMPARATOR
Intervention: Suprapubic urinary catheter (SUC) for 96 h
Number of subjects: 257
Study: 18582254

Group type: EXPERIMENTAL
Intervention: mannitol 0.5 g.kg(‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hartmann's solution (control)
Number of subjects: 50
Study: 15975729

Group type: EXPERIMENTAL
Intervention: High-frequency cocaine users
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low-frequency cocaine users
Number of subjects: 54
Study: 11821704

Group type: COMPARATOR
Intervention: High-sodium tap water (HSTW) with sodium concentration of 196 mg/l (8.5 mmol/l)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Low-sodium mineral water (LSMW) with sodium concentration of 32 mg/l (1.4 mmol/l)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Breast milk (control group)
Number of subjects: 58
Study: 10443985

Group type: EXPERIMENTAL
Intervention: Positive family history of alcohol abuse
Number of subjects: 270

Group type: COMPARATOR
Intervention: No family history of alcohol abuse
Number of subjects: 270
Study: 7742841

Group type: EXPERIMENTAL
Intervention: Ultrasound treatment on precooled tissue (preceded by 5 minutes of ice)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ultrasound with no preceding treatment
Number of subjects: 16
Study: 2258042

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine (antihistamine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (cherry syrup)
Number of subjects: 12
Study: 6998304

Group type: EXPERIMENTAL
Intervention: Transcendental meditation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Muscle relaxation
Number of subjects: 20
Study: 31740083

Group type: EXPERIMENTAL
Intervention: bi-nasal short prongs
Number of subjects: 62

Group type: COMPARATOR
Intervention: nasal mask
Number of subjects: 62
Study: 31096064

Group type: EXPERIMENTAL
Intervention: His bundle pacing (His‐CRT)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Biventricular pacing (BiV‐CRT)
Number of subjects: 41
Study: 28753064

Group type: COMPARATOR
Intervention: Nonoperative care
Number of subjects: 136
Study: 25650051

Group type: EXPERIMENTAL
Intervention: 340 mg ADS‐5102
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 260 mg ADS‐5102
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: 420 mg ADS‐5102
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 23466114

Group type: EXPERIMENTAL
Intervention: Paroxetine 20-40 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 21217528

Group type: EXPERIMENTAL
Intervention: High-pitch mode (HPM) during continuous breathing (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Breath-hold mode (group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard pitch during deep-inspiratory breath-hold (group C)
Number of subjects: 40
Study: 19922885

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15742768

Group type: EXPERIMENTAL
Intervention: Epley maneuver (canalith repositioning)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 81
Study: 12096198

Group type: EXPERIMENTAL
Intervention: Inhaled methacholine (MCh) after allergen challenge
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inhaled cysteinyl leukotriene D(4) (LTD(4)) after allergen challenge
Number of subjects: 31

Group type: COMPARATOR
Intervention: Inhaled methacholine (MCh) after control
Number of subjects: 31

Group type: COMPARATOR
Intervention: Inhaled cysteinyl leukotriene D(4) (LTD(4)) after control
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Inhaled cysteinyl leukotriene D(4) (LTD(4)) challenge reproducibility
Number of subjects: 31
Study: 10492062

Group type: EXPERIMENTAL
Intervention: Dipyrone 500 mg t.i.d.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8609254

Group type: EXPERIMENTAL
Intervention: Topical calcipotriene ointment (50 microgram/gm, maximum usage, 120 gm per week) for 8 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 78
Study: 1659983

Group type: COMPARATOR
Intervention: RESAT diet
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: EXFIB diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: STAND diet
Number of subjects: 9
Study: 7083233

Group type: COMPARATOR
Intervention: 5-FU alone
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: MFC (5-FU combined with mitomycin and cytarabine)
Number of subjects: 53
Study: 29953705

Group type: EXPERIMENTAL
Intervention: Low-saturated fat and low-cholesterol dietary counselling
Number of subjects: 193
Study: 28899771

Group type: EXPERIMENTAL
Intervention: Mechanical debridement (MD)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Mechanical debridement with adjunct antimicrobial photodynamic therapy (aPDT)
Number of subjects: 70
Study: 25877666

Group type: EXPERIMENTAL
Intervention: Terconazole vaginal suppository (80 mg for 6 days)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Oral fluconazole (150 mg, two doses)
Number of subjects: 140
Study: 23704676

Group type: EXPERIMENTAL
Intervention: Metformin plus rosiglitazone (M + R)
Number of subjects: 699

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Metformin plus lifestyle program (M + L)
Number of subjects: 699
Study: 25885385

Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg iv
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg iv
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg iv
Number of subjects: 87

Group type: COMPARATOR
Intervention: Ramosetron vs Ondansetron
Number of subjects: 87

Group type: COMPARATOR
Intervention: Ramosetron vs Palonosetron
Number of subjects: 87
Study: 19483070

Group type: EXPERIMENTAL
Intervention: Spoon-thick consistency
Number of subjects: 61

Group type: COMPARATOR
Intervention: Liquid consistency
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Bedside clinical assessment
Number of subjects: 61
Study: 17526178

Group type: EXPERIMENTAL
Intervention: Compound E‐Bei ointment (CEBO)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Daivonex
Number of subjects: 120

Group type: COMPARATOR
Intervention: Vehicle control (placebo)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CEBO
Number of subjects: 120
Study: 15679526

Group type: EXPERIMENTAL
Intervention: Creative expression program (12-week duration)
Number of subjects: 138
Study: 11803223

Group type: EXPERIMENTAL
Intervention: 25 microg misoprostol
Number of subjects: 114

Group type: COMPARATOR
Intervention: 50 microg misoprostol
Number of subjects: 114
Study: 10527993

Group type: EXPERIMENTAL
Intervention: Intramuscular progesterone (i.m. progesterone-in-oil preparation)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Intravaginal progesterone
Number of subjects: 354
Study: 8750402

Group type: EXPERIMENTAL
Intervention: Aspirin 3900 mg/d
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Bromfenac sodium 300 mg/d
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 1777605

Group type: EXPERIMENTAL
Intervention: Late intensification therapy (LIT) with high-dose methotrexate (HD-MTX) administered at 2,000 mg/m2 per dose per week, given by 24 h infusion, three doses every 12 weeks.
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Four or five courses of LIT with HD-MTX.
Number of subjects: 118
Study: 7148411

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 238
Study: 31812184

Group type: EXPERIMENTAL
Intervention: Early introduction group (EIG)
Number of subjects: 0
Study: 29897943

Group type: EXPERIMENTAL
Intervention: Replacing one hour of sitting with one hour of standing (intervention)
Number of subjects: 223
Study: 26832746

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 (Daily dosing)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 (Weekly dosing)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 (Biweekly dosing)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (no probiotics)
Number of subjects: 160
Study: 24903522

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.2 mg/kg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 23269689

Group type: EXPERIMENTAL
Intervention: Clearfil SA
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: RelyX
Number of subjects: 70

Group type: COMPARATOR
Intervention: Transbond Plus and Transbond XT (control)
Number of subjects: 70
Study: 20570980

Group type: EXPERIMENTAL
Intervention: Leader-based safety intervention encouraging safety coordinators to provide feedback on work safety to the client and line management.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 6
Study: 17215587

Group type: EXPERIMENTAL
Intervention: Sural sensory action amplitude (SAP) and peroneal motor conduction velocity (MCV)
Number of subjects: 272
Study: 15898025

Group type: EXPERIMENTAL
Intervention: Staff anesthesiologist (Group S)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Resident anesthesiologist (Group R)
Number of subjects: 220
Study: 12297935

Group type: EXPERIMENTAL
Intervention: Minisite cholecystectomy (MC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 44
Study: 9818934

Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Both treatments (plasma exchange and intravenous immunoglobulin)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Inexcitable nerves group
Number of subjects: 369

Group type: COMPARATOR
Intervention: Other groups (not inexcitable)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Axonal group
Number of subjects: 369

Group type: COMPARATOR
Intervention: Demyelinating group
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Pure motor GBS patients
Number of subjects: 369
Study: 7648483

Group type: EXPERIMENTAL
Intervention: 100 IU salmon calcitonin (5 suppositories per week)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 200 IU salmon calcitonin (3 suppositories per week)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo (5 suppositories per week)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups received 500 mg/day of calcium supplementation
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 150
Study: 2694201

Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 0
Study: 1273220

Group type: EXPERIMENTAL
Intervention: Butobarbitone 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Butobarbitone 200 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nitrazepam 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lactose dummy treatment
Number of subjects: 12
Study: 31724212

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) treatment
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Prediction model based on age, HBsAg and HBcAb quantification
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Prediction model
Number of subjects: 526
Study: 28598775

Group type: EXPERIMENTAL
Intervention: Computerised decision support system (CDSS) combined with education and feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Education and feedback alone
Number of subjects: 20
Study: 27451467

Group type: EXPERIMENTAL
Intervention: Electronic alert system for OAC prescription
Number of subjects: 889
Study: 24482066

Group type: EXPERIMENTAL
Intervention: Levofloxacin, 500 mg daily for 30 days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo for 30 days
Number of subjects: 39
Study: 22508814

Group type: COMPARATOR
Intervention: Accelerated radiotherapy (AR)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy plus carbogen inhalation and nicotinamide (ARCON)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Accelerated radiotherapy (AR) in patients with hypoxic tumors
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy plus carbogen inhalation and nicotinamide (ARCON) in patients with hypoxic tumors
Number of subjects: 345
Study: 20040610

Group type: EXPERIMENTAL
Intervention: Arformoterol (ARF) 15 microg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Arformoterol (ARF)
Number of subjects: 20
Study: 17916109

Group type: EXPERIMENTAL
Intervention: Lubiprostone 24 mcg twice daily for 4 weeks
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 15777101

Group type: EXPERIMENTAL
Intervention: Erdosteine suspension 175mg/5mL twice daily for 1 month
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 12875092

Group type: EXPERIMENTAL
Intervention: MCT/LCT lipid emulsion
Number of subjects: 72
Study: 10495375

Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finasteride 0.2 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finasteride 0.01 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8865634

Group type: EXPERIMENTAL
Intervention: Listeners' task was to indicate which complex had the greater variance in component level.
Number of subjects: 5
Study: 2006245

Group type: EXPERIMENTAL
Intervention: Intramuscular scopolamine (0.3 mg, 0.6 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oral lorazepam (2 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 7171928

Group type: EXPERIMENTAL
Intervention: Backwards counting while walking
Number of subjects: 0

Group type: COMPARATOR
Intervention: Instructions to attend to orientation
Number of subjects: 0

Group type: COMPARATOR
Intervention: No instructions given
Number of subjects: 0
Study: 31235135

Group type: EXPERIMENTAL
Intervention: Educational intervention based on social cognitive theory
Number of subjects: 120
Study: 28861746

Group type: EXPERIMENTAL
Intervention: Intraosseous local anesthesia of the inferior alveolar nerve (IAN)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Mandibular nerve (MdN) block
Number of subjects: 300

Group type: COMPARATOR
Intervention: Maxillary nerve (MxN) anesthesia
Number of subjects: 300
Study: 27832140

Group type: EXPERIMENTAL
Intervention: Compensatory auditory stimulation (CAS)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-Definition Transcranial Direct Current Stimulation (HD-tDCS)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of CAS and HD-tDCS
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 14
Study: 24630789

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 452

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 452
Study: 22130393

Group type: EXPERIMENTAL
Intervention: Constant 10 repetition maximum (RM) load for all 3 sets and for all 3 exercises
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5% reduction after the first and second sets for all the 3 exercises
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10% reduction after the first and second sets for all the 3 exercises
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 15% reduction after the first and second sets for all the 3 exercises
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 10% reduction after the first and second sets for free weight bench press
Number of subjects: 32
Study: 20727540

Group type: EXPERIMENTAL
Intervention: 10-core prostate biopsy with periprostatic nerve block
Number of subjects: 198

Group type: COMPARATOR
Intervention: 10-core prostate biopsy without periprostatic nerve block
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 20-core saturation prostate biopsy with periprostatic nerve block
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: All groups (including both biopsy types)
Number of subjects: 198